Literature DB >> 24035530

Behavioral abnormalities in progressive supranuclear palsy.

Adam Gerstenecker1, Kevin Duff, Benjamin Mast, Irene Litvan.   

Abstract

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder in which, classically, patients present with postural instability and falls, parkinsonism, and slowing of vertical saccades. PSP patients typically have deficits in cognitive functioning, difficulties with most daily activities, and present with notable behavioral disturbances-particularly apathy, impulsivity, and irritability. Using data from 154 patients meeting criteria for clinically probable PSP, domain and total scores of the Neuropsychiatric Inventory were examined and compared to demographics, disease severity, cognition, and motor features. Behavioral abnormalities were common in this cohort of PSP patients, with more than half experiencing apathy, depression, and sleeping problems, and approximately one third displaying agitation, irritability, disinhibition, and eating problems. Few clinical correlates of neuropsychiatric symptoms were observed in this cohort. Given the prevalence of neuropsychiatric symptoms in PSP, these patients are expected to be frequently seen by psychiatrists and other mental health professionals for symptom management and increased quality of life. Clinical trials are clearly needed to address the neuropsychiatric morbidity in these patients.
© 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apathy; Depression; Neuropsychiatric functioning; Neuropsychiatric inventory; Parkinsonian; Parkinsonism

Mesh:

Year:  2013        PMID: 24035530      PMCID: PMC3840159          DOI: 10.1016/j.psychres.2013.08.045

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  35 in total

1.  Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.

Authors:  Irene Litvan; Kailash P Bhatia; David J Burn; Christopher G Goetz; Anthony E Lang; Ian McKeith; Niall Quinn; Kapil D Sethi; Cliff Shults; Gregor K Wenning
Journal:  Mov Disord       Date:  2003-05       Impact factor: 10.338

2.  Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy.

Authors:  N J Cordato; C Pantelis; G M Halliday; D Velakoulis; S J Wood; G W Stuart; J Currie; M Soo; G Olivieri; G A Broe; J G L Morris
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

3.  Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.

Authors:  D Aarsland; I Litvan; J P Larsen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

4.  The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia.

Authors:  A Kertesz; N Nadkarni; W Davidson; A W Thomas
Journal:  J Int Neuropsychol Soc       Date:  2000-05       Impact factor: 2.892

5.  Risk factors for nursing home placement in advanced Parkinson's disease.

Authors:  C G Goetz; G T Stebbins
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

6.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

Review 7.  Cholinergic and peptidergic systems in PSP.

Authors:  F Javoy-Agid
Journal:  J Neural Transm Suppl       Date:  1994

8.  Health-related quality of life in patients with progressive supranuclear palsy.

Authors:  Anette Schrag; Caroline Selai; Jennifer Davis; Andrew J Lees; Marjan Jahanshahi; Niall Quinn
Journal:  Mov Disord       Date:  2003-12       Impact factor: 10.338

9.  Progressive supranuclear palsy: anatomoclinical and biochemical considerations.

Authors:  Y Agid; F Javoy-Agid; M Ruberg; B Pillon; B Dubois; C Duyckaerts; J J Hauw; J C Baron; B Scatton
Journal:  Adv Neurol       Date:  1987

10.  Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.

Authors:  Adam Gerstenecker; Benjamin Mast; Kevin Duff; Tanis J Ferman; Irene Litvan
Journal:  Arch Clin Neuropsychol       Date:  2012-11-04       Impact factor: 2.813

View more
  34 in total

1.  Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.

Authors:  Kevin Duff; Christopher Randolph; Adam L Boxer
Journal:  Clin Neuropsychol       Date:  2019-09-27       Impact factor: 3.535

2.  Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Kevin Duff; Dana McDermott; Dan Luong; Christopher Randolph; Adam L Boxer
Journal:  J Clin Exp Neuropsychol       Date:  2019-02-04       Impact factor: 2.475

Review 3.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

4.  Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.

Authors:  Andrea Horta-Barba; Javier Pagonabarraga; Saül Martínez-Horta; Laura Busteed; Berta Pascual-Sedano; Ignacio Illán-Gala; Juan Marin-Lahoz; Ignacio Aracil-Bolaños; Jesús Pérez-Pérez; Frederic Sampedro; Helena Bejr-Kasem; Jaime Kulisevsky
Journal:  J Neurol       Date:  2021-03-11       Impact factor: 4.849

5.  Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale.

Authors:  Sarah Hewer; Sue Varley; Adam L Boxer; Eldho Paul; David R Williams
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

6.  Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders.

Authors:  Leonardo Almeida; Bilal Ahmed; Roger Walz; Sol De Jesus; Addie Patterson; Daniel Martinez-Ramirez; David Vaillancourt; Dawn Bowers; Herbert Ward; Michael S Okun; Nikolaus R McFarland
Journal:  Mov Disord Clin Pract       Date:  2016-06-24

7.  Quality of life in patients with progressive supranuclear palsy: one-year follow-up.

Authors:  Tatjana Pekmezović; Milica Ječmenica-Lukić; Igor Petrović; Vladana Špica; Aleksandra Tomić; Vladimir S Kostić
Journal:  J Neurol       Date:  2015-06-13       Impact factor: 4.849

8.  Postural strategies assessed with inertial sensors in healthy and parkinsonian subjects.

Authors:  Chiara Baston; Martina Mancini; Bernadette Schoneburg; Fay Horak; Laura Rocchi
Journal:  Gait Posture       Date:  2014-03-02       Impact factor: 2.840

9.  Typical or atypical progressive supranuclear palsy: a comparative clinicopathologic study of three Chinese cases.

Authors:  Ming-Wei Zhu; Jia Liu; Thomas Arzberger; Lu-Ning Wang; Zhen-Fu Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 10.  Depressive symptoms in neurodegenerative diseases.

Authors:  Miquel Baquero; Nuria Martín
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.